Edesa Biotech (EDSA) Announces $15M Private Placement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. AA
6. RKLB
7. BLK
8. FMC
9. MRSH
10. RSG

Go back to Edesa Biotech (EDSA) Announces $15M Private Placement

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

February 13, 2025 7:00 AM EST

Financing led by Velan Capital with participation from new and existing healthcare-focused institutional investors and insidersCapital raise to fund Edesas CXCL10 antibody program through the end of fiscal 2026

TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the Company or Edesa), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that it has sold, in a private placement, an aggregate of 834 newly designated Series B-1 convertible preferred shares (Series B-1 Preferred Shares) and 3,468,746 common shares in a private placement priced at-the-market... More